Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1004 of 5804
-
Robot-Assisted surgery trial aims to ease swelling in head and neck lymphedema
Disease control Recruiting nowThe objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during open lymphatic reconstruction in the head and neck.
Phase: NA • Sponsor: MMI (Medical Microinstruments, Inc.) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a smart glucose monitor keep diabetics out of the hospital?
Disease control Not yet recruitingAmong the diffident groups of patients, those with chronic and severe medical conditions are more likely to be readmitted to the hospital. It is not surprising therefore that patients with diabetes have high readmission rates. Patients with diabetes have 40% higher re-hospitaliza…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for thalassemia: drug trial targets anemia without transfusions
Disease control Not yet recruitingThis study is a multicenter study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of treatment with SNH-119014 in adult participants with non-transfusion-dependent thalassemia. 30 participants with non-transfusion-dependent thalassemia were enrolled.
Phase: PHASE2 • Sponsor: ScinnoHub Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can adjusting guselkumab doses tame tough Crohn's cases?
Disease control Recruiting nowCrohn's disease (CD) is a chronic and destructive inflammatory disease of the gastrointestinal tract characterized by phases of relapse and remission. Tumor necrosis factor (TNF) antagonists, anti-integrins and anti-interleukin (IL) 12/23 are the main therapeutic agents to obtain…
Phase: PHASE4 • Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for kids with sanfilippo syndrome b?
Disease control Not yet recruitingThis is a global, open-label, Phase I/II, interventional trial in participants younger than 6 years of age with Mucopolysaccharidosis Type IIIB (MPS IIIB), designed to assess the safety and tolerability of JR-446, determine its pharmacodynamic effects, and explore its potential t…
Phase: PHASE1, PHASE2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug aims to shield kidneys during heart surgery
Prevention Not yet recruitingThis clinical study investigates the safety and potential effectiveness of the investigational drug SP16 in preventing acute kidney injury in patients with pre-existing chronic kidney disease who are undergoing cardiac surgery involving the use of cardiopulmonary bypass (heart-lu…
Phase: PHASE2 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
New drug CAN016 takes on advanced cancers in first human trial
Disease control Recruiting nowA Phase I/II, Open-Label, Non-Randomized, Multi-Centre First-in-Human Study of CAN016 in Patients with Advanced Solid Tumors
Phase: PHASE1, PHASE2 • Sponsor: Canwell Biotech Limited • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a botox-like injection quiet shaky hands?
Symptom relief Recruiting nowUpper limb essential tremor (UL ET) is a movement disorder characterized by postural and/or kinetic tremor. It can cause difficulty with everyday tasks such as writing, pouring, and eating. This study will assess if AGN-151607-DP is safe and effective by assessing adverse events …
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Common diabetes drug may slow rare abdominal cancer
Disease control Recruiting nowThis is a pilot, open-label clinical trial determining the feasibility of metformin therapy in subjects with pseudomyxoma peritonei (PMP) secondary to appendiceal mucinous neoplasms (AMNs).
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Stool test may predict gut healing in ulcerative colitis
Knowledge-focused ENROLLING_BY_INVITATIONThis is a national prospective, multicenter, observational study. A total of 200 eligible patients will be enrolled from 10 hospitals across the country. Inclusion criteria are as follows: aged ≥ 18 years; diagnosed with moderate-to-severe active ulcerative colitis (UC); disease …
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
One-Stop shop: new study tests dual procedure for AFib patients
Disease control Recruiting nowThe OPTION-EMEA post-market study is intended to gather real world clinical data for patients undergoing AF ablation with the FARAPULSE™ Pulsed Field Ablation (PFA) System and subsequent left atrial appendage closure (LAAC) with a WATCHMAN FLX™ Pro or WATCHMAN FLX device during o…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for myelofibrosis patients: experimental drug TQ05105 enters phase 2 trial
Disease control Recruiting nowThis is an open-label, single-arm, multi-center phase II study consisting of two cohorts. Cohort 1 evaluates the pharmacokinetics (PK) of TQ05105 in myelofibrosis participants with normal, mild, or moderate renal impairment to guide dosing. Cohort 2 evaluates the efficacy and saf…
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Vaccinia virus targets rectal tumors in new immunotherapy combo
Disease control Recruiting nowA Phase I clinical trial that will investigate the safety and tolerability of combining the modified vaccinia virus BT-001 with systemic pembrolizumab in patients with localised pMMR rectal cancer
Phase: PHASE1 • Sponsor: Henry Smith • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can we predict a deadly lung crisis? new study seeks answers
Knowledge-focused Recruiting nowThe goal of this observational study is to learn about pulmonary hypertension crisis (PHC) - a severe, and often fatal complication - in patients with pulmonary hypertension (PH). The main questions this study aims to answer are: What are the clinical and hemodynamic features of…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Balloon vs. stent: new trial could change how we treat blocked arteries
Disease control Recruiting nowThe main objective of this randomized, multicenter, international, open-label clinical trial is to demonstrate that, in the context of percutaneous coronary intervention for complex coronary artery disease, a SeQuent® SCB interventional strategy is non-inferior to a new-generatio…
Phase: NA • Sponsor: B. Braun Melsungen AG • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New shot aims to reverse cervical precancer without surgery
Disease control Not yet recruitingThe goal of this study is to learn about the safety, tolerability, immunogenicity and preliminary efficacy of BBM-C101 injection in patients with High-Grade Squamous Intraepithelial Lesion of the cervix. This study include two phases: Phase I and Phase IIa .
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Mianyi Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Caffeine trial aims to keep preterm babies breathing safely at home
Disease control Recruiting nowThe goal of this clinical trial is to learn if caffeine citrate prevents apneic events that result in sick visits in moderately preterm infants after discharge from the hospital. It will also learn if the use of caffeine leads to better developmental outcomes at 12 months of age.…
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a compound in strawberries help aging lungs?
Disease control Recruiting nowThis Phase II, randomized, double-blind, placebo-controlled pilot study will evaluate the effects of fisetin, a senolytic flavonoid compound, on lung function and biomarkers of cellular senescence in older adults aged 60 years and older. Participants will include individuals with…
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
AI-Powered tai chi and baduanjin apps tested for fall prevention in chronic illness
Disease control Not yet recruitingThis study aims to examine the effects of an AI-based mobile application delivering Tai Chi and Baduanjin exercises on balance and fall risk in adults with chronic diseases. Participants will be randomly assigned to Tai Chi, Baduanjin, or a control group over a 12-week period. T…
Phase: NA • Sponsor: Alexandria University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could a single stem cell shot ease your aching back?
Symptom relief Recruiting nowThe goal of this clinical study is to evaluate the safety and preliminary efficacy of an investigational umbilical cord blood-derived stem cell and exosome infusion in adults with chronic lower back pain associated with degenerative spine disease. The primary questions this study…
Phase: PHASE1 • Sponsor: Adia Med of Winter Park LLC • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC